Update from the LRA About CDC Recommendations on Third COVID-19 Vaccine for Immunocompromised Patients
August 13, 2021 - 4:45 PM
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices voted...
Pfizer
Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients
August 12, 2021
In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients.
Given that...
Update from LRA’s President on COVID-19 Vaccines in Lupus
January 14, 2020
Dear Friends,
Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank...
23andMe Study Confirms Lupus Can Run in Families and Other New Insights
August 25, 2020
A study started four years ago and conducted by 23andMe provided many insights about lupus as a...
VALUE Study Results Reported at EULAR
MADRID, Spain. June 13, 2019 – Results of the first clinical trial conducted through the Lupus Research Alliance Lupus...
Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies
NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance (LRA) announced the first clinical trials to be...
App developed by Lupus Research Alliance, Pfizer Inc. and Tata to be tested through non-interventional clinical trial called VALUE
NEW YORK, NY. May 9, 2017— The Lupus Research Alliance and global biopharmaceutical company Pfizer Inc.announced a non-interventional clinical...